The headline detail to know: BPC-157's evidence base is overwhelmingly preclinical. Despite a huge rodent literature, human clinical trials remain limited and it hasn't received regulatory approval in major jurisdictions. That said, it's one of the most widely used research tools in tissue repair science today.
Hundreds of preclinical studies have explored BPC-157 across:
Gut health: A standout area — gastric ulcer healing, protection against NSAID-induced damage, and inflammatory bowel models.
Tendons and ligaments: Faster healing reported in transected Achilles tendon and medial collateral ligament studies.
Muscle and bone: Crush injury recovery, fracture healing, and post-surgical models.
Vascular research: Effects on new blood vessel growth and recovery after ischemic injury.
Brain and nerve: Investigation in traumatic brain injury and spinal cord injury models.